Compositions that protect cells from oxidative and mitochondrial stress
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and cell technology, which can be used in drug combinations, skin care preparations, cosmetics, etc., to solve problems such as genome instability, DNA protection and repair ability decline, etc.
Pending Publication Date: 2021-02-26
努其杜有限公司
View PDF12 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] Decreased DNA protection and repair capacity is an important cause of genome instability
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0135] SIRT1 expression
[0136] Changes in SIRT1 expression in PBMC (peripheral blood mononuclear cells) of clinical participants were analyzed using Western blot analysis. SIRT1 expression was significantly increased within 16 days of exposure to our composition. Increased SIRT1 expression indicates that our composition activates beneficial downstream pathways associated with enhanced DNA repair.
[0137] see figure 1 .
[0138] Clinical Outcomes: Proteomics
[0139] Quantities of proteins associated with aging were determined as a function of composition using mass spectrometry.
[0140] Increased abundance of mitochondrial proteins detected in volunteer samples, including:
[0141] Fumarate hydratase: Catalyzes the hydration of fumarate to L-malate in the tricarboxylic acid (TCA) cycle to facilitate a transition step in energy production in the form of NADH.
[0142] Aspartate transaminase: Catalyzes the transamination of the L-tryptophan metabolite L-kynurenine to f...
Embodiment 2
[0153] HDF Results: Protection Against Oxidative Stress
[0154] Preprocess with NAM or a combination
[0155] Subsequent exposure to oxidative stress (tbh7ox)
[0156] Measure cell viability to assess protection against oxidative stress
[0157] Our Composition Offers Better Protection Than Niacinamide
[0158] The composition is required to produce this enhanced protection as predicted by systems pharmacology
[0159] The composition is alpha lipoic acid, apigenin, ascorbic acid, zinc citrate, niacinamide and quercetin. The results are shown in figure 2 middle.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
particle size
aaaaa
aaaaa
diameter
aaaaa
aaaaa
diameter
aaaaa
aaaaa
Login to view more
Abstract
There are described compositions comprising an effective amount of a combination of two or more components, said components selected from acacetin, ACT1 peptide, alpha-lipolic acid, alprostadil, anisomycin, apigenin, ascorbic acid, astragalus, berberine, beta-lapachone, beta-hydroxy-beta-methyl-butyrate, bacopa monnieri, catechin, catechol, chamomile, chrysin, coumestrol, curcumin, dinitrophenol,dinoprost, ellagic acid, (-)-epigallocatechin gallate, green tea extract, fisetin, genistein, ginsenoside RE, glabridin, 18-alfa-glycyrrhetinic acid, 18-beta-glycyrrhetinic acid, glycyrrhizin, hydroquinone, isoquercitrin (EMIQ), kaempferol, kuromanin, leucine, lithium, luteolin, luteolin, luteolinidin, melatonin, menadione, 1-methylnicotinamide (MNA), methyl salicylate, myricetin, nadide, niacin (vitamin B3), nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid adenine dinucleotide (Na AD), nicotinic acid mononucleotide (Na MN), parsley (petroselinium crispum), phenylephrine, pokeweed mitogen, 15-Delta prostaglandin J2, puromycin, quercetin, quinolinic acid, retinoic acid, trichostatin A, troxrutin, rutin, tryptophan, vitamin D3, withaferin A, wortmannin and zinc (including salts thereof).
Description
technical field [0001] The present invention relates to novel compositions commonly used for oral or topical application to alleviate the effects of aging. [0002] In particular, the present invention relates to compositions and methods for enhancing cellular tolerance to DNA damage, oxidative stress, mitochondrial dysfunction, or enhancing DNA repair capacity. Background technique [0003] Decreased DNA protection and repair capacity is an important cause of genome instability. Genome instability in turn may lead to diseases such as cancer, the risk of which increases exponentially with age. [0004] Protecting DNA and other vital cellular mechanisms from damage and repairing it when damage occurs is critical for highly functioning cells. This protection and repair of cells is often associated with youth and health. Furthermore, these protective and repair functions decline in somatic cells with age and are responsible for the decline of most cellular and tissue functio...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more